NCT00045097View on ClinicalTrials.gov

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2002

Study Completion Date

July 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

ixabepilone

Trial Locations (4)

20814

Suburban Hospital, Bethesda

20817

Oncology Care Associates, Bethesda

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00045097 - Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter